Azzur Cleanrooms on Demand (COD) has entered this acronym-laden environment to provide cleanroom and laboratory spaces for so-called GxP manufacturing support. Opened in May 2023, it’s a 75,000-square ...

IMMvention Therapeutix, Inc., a Durham early-stage biotechnology company focused on discovering and developing human ...

Ed Field discovered his passion for building biotechnology innovation while working with an equity-backed biopharma start-up ...

PharmAgra Labs, a custom chemical research and development company in Brevard, has been bought by Chinese contract manufacturer Raybow Pharmaceutical. The companies did not disclose financial details.

The following FAQs assist applicants with preparing proposals for NCBiotech research grant programs. Please refer to the program web pages for current guidelines and application instructions.

Networking. Training events. Employment opportunities. NCBiotech can connect you with the next job or company you need to advance your career in life sciences. North Carolina is home to 840 life ...

North Carolina, rich in scientific expertise and supporting resources, is one of the nation’s best places to start a life science enterprise, a panel of early stage company entrepreneurs agreed at the ...

Human organ transplants became possible in 1954 when a kidney became the first organ to be transplanted successfully, eventually earning Boston physician Joseph Murray the Nobel Prize. Today, it’s ...

BMI OrganBank has secured a $3.5 million federal grant that will help the Winston-Salem company advance its kidney preservation technology and prepare for clinical trials.

Bioventus, a global orthobiologics company based in Durham, has launched Durolane, its single-injection, hyaluronic acid (HA) joint lubricant for treating knee osteoarthritis pain, following FDA ...

BMI OrganBank has secured a $3.5 million federal grant that will help the Winston-Salem company advance its kidney preservation technology and prepare for clinical trials. The Phase 2 Small Business ...

FUJIFILM Diosynth Biotechnologies, a global contract development and manufacturing organization (CDMO), plans to invest $1.2 billion to double the size of its manufacturing facility currently under ...